rs201847314

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBS1BS2

The NM_001394998.1(TANC2):​c.53A>G​(p.Lys18Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000213 in 1,612,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00022 ( 0 hom. )

Consequence

TANC2
NM_001394998.1 missense

Scores

1
6
12

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 5.92

Publications

3 publications found
Variant links:
Genes affected
TANC2 (HGNC:30212): (tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2) Predicted to be involved in dense core granule cytoskeletal transport; regulation of dendritic spine development; and regulation of dendritic spine morphogenesis. Predicted to act upstream of or within in utero embryonic development. Located in dendritic spine. [provided by Alliance of Genome Resources, Apr 2022]
TANC2 Gene-Disease associations (from GenCC):
  • intellectual developmental disorder with autistic features and language delay, with or without seizures
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Illumina, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, ClinGen
  • syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.22013274).
BP6
Variant 17-63009612-A-G is Benign according to our data. Variant chr17-63009612-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 2225665.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000171 (26/152300) while in subpopulation NFE AF = 0.000235 (16/68014). AF 95% confidence interval is 0.000147. There are 0 homozygotes in GnomAd4. There are 11 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 26 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TANC2NM_001394998.1 linkc.53A>G p.Lys18Arg missense_variant Exon 2 of 28 ENST00000689528.1 NP_001381927.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TANC2ENST00000689528.1 linkc.53A>G p.Lys18Arg missense_variant Exon 2 of 28 NM_001394998.1 ENSP00000510600.1 A0A8I5KXR5
TANC2ENST00000424789.6 linkc.53A>G p.Lys18Arg missense_variant Exon 1 of 25 1 ENSP00000387593.2 Q9HCD6-1
TANC2ENST00000389520.8 linkc.53A>G p.Lys18Arg missense_variant Exon 1 of 26 5 ENSP00000374171.4 Q9HCD6-2

Frequencies

GnomAD3 genomes
AF:
0.000171
AC:
26
AN:
152182
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000117
AC:
29
AN:
248740
AF XY:
0.0000963
show subpopulations
Gnomad AFR exome
AF:
0.000194
Gnomad AMR exome
AF:
0.0000872
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000142
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000218
AC:
318
AN:
1460682
Hom.:
0
Cov.:
30
AF XY:
0.000217
AC XY:
158
AN XY:
726644
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33436
American (AMR)
AF:
0.0000448
AC:
2
AN:
44642
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26096
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39594
South Asian (SAS)
AF:
0.000174
AC:
15
AN:
86208
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53378
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.000262
AC:
291
AN:
1111248
Other (OTH)
AF:
0.000133
AC:
8
AN:
60318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
15
30
44
59
74
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000171
AC:
26
AN:
152300
Hom.:
0
Cov.:
32
AF XY:
0.000148
AC XY:
11
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.000192
AC:
8
AN:
41574
American (AMR)
AF:
0.0000655
AC:
1
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
68014
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000174
Hom.:
1
Bravo
AF:
0.000136
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000534
AC:
2
ESP6500EA
AF:
0.000243
AC:
2
ExAC
AF:
0.000124
AC:
15
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Oct 12, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.26
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.069
T;.
Eigen
Uncertain
0.40
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.90
D;D
M_CAP
Benign
0.0091
T
MetaRNN
Benign
0.22
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.55
N;N
PhyloP100
5.9
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-0.46
N;N
REVEL
Benign
0.19
Sift
Uncertain
0.010
D;D
Sift4G
Benign
0.19
T;T
Polyphen
0.96
P;.
Vest4
0.60
MVP
0.56
MPC
0.24
ClinPred
0.14
T
GERP RS
5.6
PromoterAI
0.0014
Neutral
Varity_R
0.13
gMVP
0.17
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201847314; hg19: chr17-61086973; COSMIC: COSV99067301; COSMIC: COSV99067301; API